3902 — Medical Data Vision Co Share Price
0.000.00%
Last trade - 00:00- ¥15bn
- ¥14bn
- ¥6bn
- 75
- 16
- 25
- 29
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 18.04 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | 2.06% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.9 | ||
| Price to Tang. Book | 5 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.57 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -6.46% | ||
| Return on Equity | -21.52% | ||
| Operating Margin | -3.62% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 4,579.73 | 5,672.3 | 6,104.6 | 6,419.03 | 5,906.96 | 7,838 | 8,822 | 7.97% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +13.48 | +43.02 | +4.54 | -5.86 | n/a | n/a | +28.44 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medical Data Vision Co.,Ltd. is a company engaged in the medical data network business. The Data Network Service provides management support systems for medical institutions and health insurance unions, as well as EVE, Medical Code and CADA-BOX for hospitals. The Data Utilization Service provides corporate services and personal services based on the medical and health information accumulated through the data network services, various analysis data to pharmaceutical companies, research institutes, patients and consumers. The segment provides various services, such as MDV analyzer, ADHOC research service, OTC, H&BC and insurance company services, as well as Media logs and others.
Directors
- Hiroyuki Iwasaki PRE (57)
- Shuji Asami SMD (61)
- Philip Ovalo EXO (57)
- Takuji Yanagisawa OTH (45)
- Taro Inoue OTH (56)
- Masaki Nakamura OTH (36)
- Yuko Kimura DRC (60)
- Hiroaki Fujimiya IND (70)
- Nobuhiro Kato IND (50)
- Soichi Katsuki IND (66)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 20th, 2003
- Public Since
- December 16th, 2014
- No. of Employees
- 262
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 37,856,778
- Address
- 10F, Sumitomo Fudosan Kanda Bldg.7, CHIYODA-KU, 101-0053
- Web
- https://www.mdv.co.jp/
- Phone
- +81 352836911
- Auditors
- Deloitte Touche Tohmatsu LLC
Upcoming Events for 3902
Dividend For 3902.T - 0.0000 JPY
Similar to 3902
Alfresa Holdings
Tokyo Stock Exchange
Asahi Intecc Co
Tokyo Stock Exchange
Aso International
Tokyo Stock Exchange
As One
Tokyo Stock Exchange
Atect
Tokyo Stock Exchange
FAQ
What is the Medical Data Vision Co share price?
As of Today at 02:58 UTC, shares in Medical Data Vision Co are trading at ¥401. This share price information is delayed by 15 minutes.
How has the Medical Data Vision Co share price performed this year?
Shares in Medical Data Vision Co last closed at ¥401 and the price had moved by -29.03% over the past 365 days. In terms of relative price strength the Medical Data Vision Co share price has underperformed the Nikkei 225 Index by -25.67% over the past year.
What are the analyst and broker recommendations for Medical Data Vision Co?
The overall consensus recommendation for Medical Data Vision Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Medical Data Vision Co dividend yield?
The Medical Data Vision Co dividend yield is 1.62% based on the trailing twelve month period.
Does Medical Data Vision Co pay a dividend?
Last year, Medical Data Vision Co paid a total dividend of ¥7, and it currently has a trailing dividend yield of 1.62%.Looking ahead, the next dividend pay date is 2025-03-26.
When does Medical Data Vision Co next pay dividends?
We do not have data on when Medical Data Vision Co is to next pay dividends. The historic dividend yield on Medical Data Vision Co shares is currently 1.62%.
How do I buy Medical Data Vision Co shares?
To buy shares in Medical Data Vision Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Medical Data Vision Co?
As of the previous close price of ¥401, shares in Medical Data Vision Co had a market capitalisation of ¥15bn.
Where are Medical Data Vision Co shares listed?
Here are the trading details for Medical Data Vision Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 3902
What kind of share is Medical Data Vision Co?
Based on an overall assessment of its quality, value and momentum Medical Data Vision Co is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Medical Data Vision Co share price forecast for 2025?
The analyst consensus target price for shares in Medical Data Vision Co is ¥430. That is 7.23% above the last closing price of ¥401.
Analysts covering Medical Data Vision Co currently have a consensus Earnings Per Share (EPS) forecast of ¥21 for the next financial year.
Find out moreWhat is the trend in the Medical Data Vision Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medical Data Vision Co. Over the past six months, its share price has underperformed the Nikkei 225 Index by -21.32%.
As of the last closing price of ¥401, shares in Medical Data Vision Co were trading -18.63% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Medical Data Vision Co PE Ratio?
The Medical Data Vision Co PE ratio based on its reported earnings over the past 12 months is 18.04. The shares last closed at ¥401.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Medical Data Vision Co?
Medical Data Vision Co's management team is headed by:
- Hiroyuki Iwasaki - PRE
- Shuji Asami - SMD
- Philip Ovalo - EXO
- Takuji Yanagisawa - OTH
- Taro Inoue - OTH
- Masaki Nakamura - OTH
- Yuko Kimura - DRC
- Hiroaki Fujimiya - IND
- Nobuhiro Kato - IND
- Soichi Katsuki - IND